283 related articles for article (PubMed ID: 16257182)
1. Color vision and contrast sensitivity in epilepsy patients treated with initial tiagabine monotherapy.
Sorri I; Kälviäinen R; Mäntyjärvi M
Epilepsy Res; 2005 Dec; 67(3):101-7. PubMed ID: 16257182
[TBL] [Abstract][Full Text] [Related]
2. Visual function in epilepsy patients treated with initial valproate monotherapy.
Sorri I; Rissanen E; Mäntyjärvi M; Kälviäinen R
Seizure; 2005 Sep; 14(6):367-70. PubMed ID: 15939631
[TBL] [Abstract][Full Text] [Related]
3. Color vision in epilepsy patients treated with vigabatrin or carbamazepine monotherapy.
Nousiainen I; Kälviäinen R; Mäntyjärvi M
Ophthalmology; 2000 May; 107(5):884-8. PubMed ID: 10811079
[TBL] [Abstract][Full Text] [Related]
4. Contrast sensitivity and color vision in HIV-infected individuals without infectious retinopathy.
Shah KH; Holland GN; Yu F; Van Natta M; Nusinowitz S;
Am J Ophthalmol; 2006 Aug; 142(2):284-92. PubMed ID: 16876510
[TBL] [Abstract][Full Text] [Related]
5. Color vision in 42 Congolese patients with tuberculosis receiving ethambutol treatment.
Kaimbo WK; Bifuko ZA; Longo MB; Dralands L; Missotten L
Bull Soc Belge Ophtalmol; 2002; (284):57-61. PubMed ID: 12161991
[TBL] [Abstract][Full Text] [Related]
6. [Disorders of color perception and increase glare sensitivity in phenytoin and carbamazepine therapy. Ocular side effects of anticonvulsants].
Bayer A; Thiel HJ; Zrenner E; Paulus W; Ried S; Schmidt D
Nervenarzt; 1995 Feb; 66(2):89-96. PubMed ID: 7715759
[TBL] [Abstract][Full Text] [Related]
7. Color vision and macular recovery time in epileptic adolescents treated with valproate and carbamazepine.
Verrotti A; Lobefalo L; Tocco AM; Spalice A; Gallenga PE; Chiarelli F; Iannetti P
Eur J Neurol; 2006 Jul; 13(7):736-41. PubMed ID: 16834703
[TBL] [Abstract][Full Text] [Related]
8. Tolerability of tiagabine: a prospective open-label study.
Bauer J; Bergmann A; Reuber M; Stodieck SR; Genton P
Epileptic Disord; 2002 Dec; 4(4):257-60. PubMed ID: 12600812
[TBL] [Abstract][Full Text] [Related]
9. A review of the antiepileptic drug tiagabine.
Schachter SC
Clin Neuropharmacol; 1999; 22(6):312-7. PubMed ID: 10626090
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the cognitive effects of tiagabine and carbamazepine as monotherapy in newly diagnosed adult patients with partial epilepsy: pooled analysis of two long-term, randomized, follow-up studies.
Aikiä M; Jutila L; Salmenperä T; Mervaala E; Kälviäinen R
Epilepsia; 2006 Jul; 47(7):1121-7. PubMed ID: 16886974
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of tiagabine monotherapy on cognition and mood in adult patients with chronic partial epilepsy.
Aikiä M; Jutila L; Salmenperä T; Mervaala E; Kälviäinen R
Epilepsy Behav; 2006 Jun; 8(4):750-5. PubMed ID: 16647884
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the standard pseudoisochromatic plates--Parts 1 and 2--As screening tests for congenital red-green color vision deficiencies.
Hovis JK; Cawker CL; Cranton D
J Am Optom Assoc; 1996 Jun; 67(6):320-6. PubMed ID: 8888852
[TBL] [Abstract][Full Text] [Related]
13. [Sensitive physiologic perceptual tests for ocular side effects of drugs exemplified by various anticonvulsants].
Bayer A; Thiel HJ; Zrenner E; Paulus W; Ried S; Schmidt D
Ophthalmologe; 1995 Apr; 92(2):182-90. PubMed ID: 7780278
[TBL] [Abstract][Full Text] [Related]
14. [Use of a new anomaloscope test in diagnosis of glaucoma].
Nguyen NX; Korth M; Wisse M; Jünemann A
Klin Monbl Augenheilkd; 1994 Mar; 204(3):149-54. PubMed ID: 8196300
[TBL] [Abstract][Full Text] [Related]
15. Poor visual discrimination and visual hallucinations in Parkinson's disease.
Diederich NJ; Goetz CG; Raman R; Pappert EJ; Leurgans S; Piery V
Clin Neuropharmacol; 1998; 21(5):289-95. PubMed ID: 9789709
[TBL] [Abstract][Full Text] [Related]
16. [Study on FM100-HUE color vision in male workers exposed to lower concentration of carbon disulfide].
Wang C; Tan X; Bi Y; Yan J
Wei Sheng Yan Jiu; 2001 May; 30(3):179-81. PubMed ID: 12525096
[TBL] [Abstract][Full Text] [Related]
17. Technical note: the effect of refractive blur on colour vision evaluated using the Cambridge Colour Test, the Ishihara Pseudoisochromatic Plates and the Farnsworth Munsell 100 Hue Test.
Thyagarajan S; Moradi P; Membrey L; Alistair D; Laidlaw H
Ophthalmic Physiol Opt; 2007 May; 27(3):315-9. PubMed ID: 17470246
[TBL] [Abstract][Full Text] [Related]
18. Color vision defect type and spatial vision in the optic neuritis treatment trial.
Schneck ME; Haegerstrom-Portnoy G
Invest Ophthalmol Vis Sci; 1997 Oct; 38(11):2278-89. PubMed ID: 9344351
[TBL] [Abstract][Full Text] [Related]
19. Color vision tests for early detection of antiepileptic drug toxicity.
Bayer AU; Thiel HJ; Zrenner E; Dichgans J; Kuehn M; Paulus W; Ried S; Schmidt D
Neurology; 1997 May; 48(5):1394-7. PubMed ID: 9153479
[TBL] [Abstract][Full Text] [Related]
20. Visual fields and tiagabine: a quandary.
Kaufman KR; Lepore FE; Keyser BJ
Seizure; 2001 Oct; 10(7):525-9. PubMed ID: 11749112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
